Shanghai Haohai Biological Technology Co. Ltd (5HB) — Capital Reinvestment Ratio
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Capital Reinvestment Ratio of 0.37x as of June 2023, meaning it reinvests 0% of its operating cash flow (€141.99 Million) in capital expenditures (€53.01 Million). See 5HB net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Haohai Biological Technology Co. Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Shanghai Haohai Biological Technology Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. Check cash flow reinvestment rate of Shanghai Haohai Biological Technology Co to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Haohai Biological Technology Co. Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2024. For live market cap and broader valuation context, see 5HB market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.56x | €648.57 Million | €365.49 Million | ▲ +4.2% |
| 2023 | 0.54x | €634.45 Million | €343.10 Million | ▼ -59.5% |
| 2022 | 1.34x | €231.30 Million | €309.21 Million | ▲ +68.9% |
| 2021 | 0.79x | €342.29 Million | €270.88 Million | ▲ +9.3% |
| 2020 | 0.72x | €262.07 Million | €189.70 Million | ▲ +1.4% |
| 2019 | 0.71x | €348.91 Million | €249.18 Million | ▲ +84.8% |
| 2018 | 0.39x | €391.28 Million | €151.21 Million | ▼ -1.3% |
| 2017 | 0.39x | €343.06 Million | €134.29 Million | ▲ +31.7% |
| 2016 | 0.30x | €254.49 Million | €75.67 Million | — |